Switch to biosimilar drugs may pose legal challenges for doctors

The Alberta government’s plan for many arthritis, diabetes and Crohn’s disease patients to switch to less expensive medications by July 1 could create legal challenges for doctors, say two researchers at the University of Alberta.
Read More

Leave a comment